STEPHEN WINFIELD: Open Payments
NPI 1992156970 · CHAMPLAIN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 76 payments from 17 companies in 2025. Trend: 2023 $380 · 2024 $1,308 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $287 |
| ABBVIE INC. | 11 | $248 |
| Novo Nordisk Inc | 10 | $192 |
| Amgen Inc. | 12 | $150 |
| Lundbeck LLC | 5 | $128 |
| Viatris Specialty LLC | 3 | $76 |
| Lilly USA, LLC | 4 | $69 |
| PFIZER INC. | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
Products named: REXULTI, Ozempic, BREZTRI, QULIPTA, OTEZLA, FARXIGA, YUPELRI, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
